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Abstract
Background: Determinants of intrafamilial HCV transmission are still being debated. The aim of this
study is to investigate the correlates of HCV seropositivity among familial contacts of HCV positive
patients in Italy.
Methods: A cross-sectional study was conducted with 175 HCV positive patients (index cases), recruited
from Policlinico Gemelli in Rome as well as other hospitals in Central Italy between 1995 and 2000 (40%
female, mean age 57 ± 15.2 years), and 259 familial contacts. Differences in proportions of qualitative
variables were tested with non-parametric tests (χ2, Yates correction, Fisher exact test), and a p value <
0.05 was considered significant. A multivariate analysis was conducted using logistic regression in order to
verify which variables statistically have an influence on HCV positivity in contact individuals.
Results: Seropositivity for HCV was found in 8.9% of the contacts.
From the univariate analysis, risk factors significantly associated to HCV positivity in the contacts were:
intravenous drug addiction (p = 0.004) and intercourse with drug addicts (p = 0.005).
The only variables associated significantly and independently to HCV seropositivity in patients' contacts
were intercourse with drug addicts (OR = 19.28; 95% CI: 2.01 – 184.94), the retirement status from work
(OR = 3.76; 95% CI: 1.17 – 11.98), the time of the relationship (OR = 1.06; 95% CI: 1.00 – 1.11) and tattoos
(OR = 7.68; 95% CI: 1.00 – 60.20).
Conclusion: The present study confirms that having intercourse with a drug addict is the most significant
risk factor for intrafamilial HCV transmission. The association with retirement status from work could be
related to both a long-term relationship with an index case and past exposure to common risk factors.
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Background
Since its discovery in 1989, hepatitis C virus (HCV) has
represented a major cause of chronic liver disease world-
wide. The most recent WHO estimate of the prevalence of
HCV infection is 2%, representing 123 million people.
HCV is the leading cause of liver transplantation in devel-
oped countries, and the most common chronic blood-
borne infection in the USA [1]. Although HCV is endemic
in most parts of the world, there are significant geographic
and temporal differences in the incidence and prevalence
of HCV infection. Africa and Asia have the highest
reported prevalence rates; while industrialized countries
in North America, northern and western Europe and Aus-
tralia have a lower prevalence. Nations with relatively low
rates of HCV seroprevalence include Germany (0.6%),
Canada (0.8%), France (1.1%), and Australia (1.1%).
Low, but slightly higher seroprevalence rates have been
reported in the USA (1.8%) and Japan (1.5–2.3%) [2].
The few studies on prevalence of HCV infection in Italy
suggest an average value of 7–8%, increasing with age and
from north to south [3-5]. With regards to developing
countries, there is less data available about the burden of
disease. Considering the most populous countries, China
has a reported seroprevalence of 3.2%; India, 0.9%; while
Egypt has the highest reported prevalence rate of 22% [2].
HCV infection appears in both acute and chronic clinical
forms, but most of the morbidity is associated with
chronic infection. 50–60% of HCV patients develop
chronic hepatitis, which could result in severe liver dis-
ease, cirrhosis or even hepatocellular carcinoma [6]. How-
ever, assessing the incidence of HCV infection is difficult
because most infections are initially asymptomatic (with
only slightly increased ALT levels) [7].
The transmission of HCV infection usually involves the
parental route. In fact, transmission through transfusions
of blood or blood products from unscreened donors,
injection drug use, unsafe therapeutic injections, occupa-
tional injury by needles or sharp instruments contami-
nated with blood, hemodialysis and tattooing is well
documented [8,9]. However, at least 50% of all HCV pos-
itive patients do not have a history of blood transfusion or
exposure to any other parenteral risk factor [10]. There-
fore, it has been hypothesized that there must be other
modes of HCV transmission in these patients. Kim et al.
have previously found that horizontal transmission plays
a major role in the spread of the hepatitis B virus (HBV)
infection among family members of adults who are
chronic carriers of HBsAg [11]. Familiar clustering of HCV
infection has been demonstrated in epidemiological stud-
ies, but it is still controversial whether HCV can be trans-
mitted through horizontal transmission to partners or
other household contacts [10,12,13]. Furthermore, in
Italy, despite increased frequency of HCV seropositivity in
family members of patients with chronic HCV infection
[14], the transmission of this virus through non-sexual
household contacts has been regarded as uncommon
[15]. As far as other vehicles of transmission is concerned,
it is well known that HCV RNA titres in body fluids, such
as saliva, semen, urine and vaginal fluids, are very low
[16-18].
The aim of this study is to investigate the correlates of
HCV seropositivity among familial contacts of HCV posi-
tive patients in Central Italy.
Methods
Patients and methods
A cross-sectional study was conducted with HCV positive
patients (index cases), recruited from Policlinico Gemelli
in Rome as well as other hospitals in Central Italy between
1995 and 2000, and their familiar contacts.
Sample size calculations (alpha = 0.05; beta = 0.20) sug-
gested to sample size of at least 180 patients.
175 anti-HCV positive patients with chronic liver disease
(identified as "index cases") were selected (97.2% of the
eligible individuals) and a questionnaire was adminis-
tered to them in order to evaluate their risk factors for
HCV transmission. Then, the family members were tested
for anti-HCV and interviewed to identify transmission risk
factors. Participation was voluntary in accordance with
the Guidelines for Observational Non-Interventional
Studies from the Ethical Committee of the Gemelli Teach-
ing Hospital. The research was conducted according to the
Helsinki Declaration.
All 175 (70 females and 105 males, mean age 57 ± 15.2
years) patients who underwent a periodic health examina-
tion and tested positive for the antibody anti-HCV
between July 1995 and December 2000 at the Policlinico
"Gemelli", Ambulatory for Liver Disease, and at the other
hospitals participating in the study in Southern Lazio
(Central Italy) were enrolled in the study. Members of
their family who were living together in the same house
were studied. All patients had been living within this geo-
graphical area for at least ten years. All participants pro-
vided verbal consent to be in the study.
We enrolled 175 patients and 259 family members of 175
index cases into the study. Of these 175 patients, 142
(81.1%) had a clinical-histological diagnosis of chronic
active hepatitis (CAH), 31 (17.7%) cirrhosis and 2 (1.1%)
hepatocellular carcinoma (HCC). These patients were
treated according to international therapeutical protocols.
All of the participants were assessed for HCV infection and
liver disease by testing for anti-HCV antibody using aBMC Public Health 2006, 6:237 http://www.biomedcentral.com/1471-2458/6/237
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commercial ELISA, which was then confirmed by RIBA
assay, alanine aminotransferase (ALT), aspartate ami-
notrasferase (AST), HBs Ag, HBs Ab, HBc Ab, polymerase
chain reaction (PCR) as well as by ultrasound examina-
tion.
By means of a questionnaire, participants were asked
about their past medical history, including surgical, dental
and other possible risky procedures, blood or hemoderi-
vates transfusions, hemodialysis, jaudice, tattoos, piercing
and IV drug use.
Statistical analysis
Quantitative variables were expressed as mean ± standard
deviation and were compared by Student's t-test. Differ-
ences in the proportions of qualitative variables were
tested with non-parametric tests (χ2, Yates correction,
Fisher exact test), and a p value < 0.05 was considered sig-
nificant. A multivariate analysis was conducted using
logistic regression in order to verify which variables statis-
tically had an influence on HCV positivity in contact indi-
viduals. The following variables were considered as
covariates: gender [males (reference group) vs females],
age group [<25 years; 25–49 years (reference group); ≥ 50
years]; job [manager; non-manual skilled; manual skilled
(reference group); unemployed/student; retired from
work]; intravenous drug users [yes vs no]; transfusions
[yes vs no]; job with high risk of contamination [yes vs
no]; surgical interventions with transfusions [yes vs no];
oral care [yes vs no]; hemodialitic treatments [yes vs no];
tattoos [yes vs no]; stable relationship with partner [yes vs
no]; intercourse with drug addicts [yes vs no] and journey
abroad [yes vs no].
We followed the procedure suggested by Hosmer and
Lemeshow, using a stepwise approach (backward elimina-
tion). The goodness-of-fit of the model was assessed using
the Hosmer-Lemeshow test for significance.
Results
In table 1 the socio-characteristics of HCV patients and
their contacts are shown.
The 259 household contacts (155 females, 104 males)
had a mean age of 40.4 ± 19.0 years and included 99 het-
erosexual partners, 19 parents, 117 children, 10 siblings
and 14 other relatives. Among these 23 were found to be
positive for anti HCV. Eight of the anti HCV positive con-
tacts had a known parenteral risk factor. The prevalence of
anti HCV positivity in all household contacts was 8.9%
(23/259). Excluding those with previous parenteral expo-
sure, the proportion of anti HCV in family contacts was
6.0% (15/251). The highest prevalence was found in sex-
ual partners (12.1%), followed by children (2.6%). The
prevalence of anti-HCV increased with age (being highest
in family contacts who were older than 60), as well in the
sexual and non-sexual contacts groups. The proportion of
anti HCV positive cases among household contacts with
increased ALT and/or AST was 17.4% (4/23) versus 8.0%
(19/236) among household contact with a normal ALT
and/or AST (p = 0.132).
The prevalence of anti HCV in the contacts was not differ-
ent when the clinical diagnosis of the index patients was
taken into account. There was a significant difference in
the duration of relationships with the index cases between
anti-HCV positive contacts and anti-HCV negative con-
tacts (35.2 ± 12 vs 26.5 ± 11.4). According to the distribu-
tion of HCV positive sexual contacts and to the duration
Table 1: Socio-demographic characteristics of Patients HCV positive and their Contacts.
Variables HCV patients Contacts p *
HCV positive HCV negative
Age (standard deviation) 55,77 (15,197) 50,52 (18,81) 39,13 (19,05) 0,07
Gender
Males 105 (60.0%) 8 (34,8%) 93 (42,5%) 0,447
Females 70 (40,0%) 15 (65,2%) 126 (57,5%)
Province of residence
Caserta 15 (8,6%)
Frosinone 43 (24,6%)
Latina 117 (65,4%)
Occupational Activity
Manager 5 (2,9%) 1 (4,3%) 17 (7,8%) 0,072
Non Manual skilled 31 (17,7%) 1 (4,3%) 35 (16,1%)
Manual skilled 73 (41,7%) 10 (43,5%) 79 (36,2%)
Unemployed/Student 12 (6,9%) 4 (17,4%) 61 (28,0%)
Retired from work 54 (30,9%) 7 (30,4%) 26 (11,9%)
* p value refers to tests of significance within the contacts' groupBMC Public Health 2006, 6:237 http://www.biomedcentral.com/1471-2458/6/237
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of relationship, the detection frequency for anti-HCV
increased in proportion to the duration of relationship.
It is interesting to note that the transmission of HCV was
more likely in females (OR = 1.38; 95%CI: 0.52 – 3.74),
however this pattern is not statistically significant.
In table 2 risk factors associated to HCV positivity in HCV
patients and their contacts are shown. It can be deduced
that the following variables are significantly associated to
HCV seropositivity in patient contacts: intravenous drug
use (p = 0.004) and intercourse with drug addicts (p =
0.005). As far as the differences in HCV seropositivities
between index cases and their contacts is concerned, there
was no significant different pattern in risk factors, with
only blood transfusions approaching significance (26% in
HCV patients vs. 4.8% in their contacts; p = 0.06).
The prevalence of anti-HCV among household contacts,
excluding cases with previous parenteral exposure, in this
study was 6.2%. These results are higher than in other
studies but are similar to the prevalence of anti-HCV in
our control group (5.2%). These results support the hypo-
tesis that Southern Lazio is an area with an elevated distri-
bution of HCV. Moreover, the prevalence of anti-HCV in
sexual contacts (12.1%) was higher than in non sexual
contacts (2.5%), but not so high as to suggest that HCV
can be sexually transmitted.
The higher prevalence among older contacts may be due
to the duration of their relationship with the index case
but also to the re-use of medical materials (syringes for
intramuscle injections) administered at home (once com-
mon in Italy).
The substantial percentage of seropositive contacts with
no identifiable risk factors supports the hypothesis of
unapparent parenteral transmission of the virus.
In table 3 the results of the multivariate analysis are pre-
sented. After controlling for age and gender, the only var-
iables associated significantly and independently to HCV
Table 2: Risk factors associated to HCV seropositivity
Variables HCV patients Contacts p *
HCV positive HCV negative
Intravenous drug addiction
Yes 14 (9,3%) 2 (9,5%) 2 (0,9%) 0,004
No 136 (90,7%) 19 (90,5%) 209 (99,1%)
Blood transfusions
Yes 39 (26,0%) 1 (4,8%) 10 (4,8%) 0,996
No 111 (74,0%) 20 (95,2%) 199 (95,2%)
Job at risk of contamination
Yes 7 (4,7%) 1 (4,8%) 8 (3,8%) 0,837
No 142 (95,3%) 20 (95,2%) 200 (96,2%)
Surgical intervention with blood transfusions
Yes 28 (19,0%) 1 (4,8%) 8 (3,8%) 0,826
No 119 (81,0%) 20 (95,2%) 203 (96,2%)
Dental care
Yes 112 (75,7%) 15 (71,4%) 154 (74,4%) 0,768
No 36 (24,3%) 6 (28,6%) 53 (25,6%)
Hemodialytic treatments
Yes 0 0 1 (0,5%) 0,749
No 148 (100%) 21 (100%) 205 (99,5%)
Tattoos
Yes 6 (4,1%) 2 (9,5%) 6 (2,9%) 0,111
No 142 (95,9%) 19 (90,5%) 204 (97,1%)
Stable relationship with partner
Yes 123 (83,1%) 17 (81,0%) 142 (67,9%) 0,219
No 25 (16,9%) 4 (19,0%) 67 (32,1%)
Intercourse with drug addicts
Yes 5 (3,4%) 2 (9,5%) 2 (1,0%) 0,005
No 141 (96,6%) 19(90,5%) 198 (99,0%)
Journey abroad
Yes 62 (41,3%) 8 (38,1%) 74 (35,6%) 0,819
No 88 (58,7%) 13 (61,9%) 134 (64,4%)
* p value refers to tests of significance within the contacts' groupBMC Public Health 2006, 6:237 http://www.biomedcentral.com/1471-2458/6/237
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seropositivity in patients' contacts are intercourse with
drug addicts (OR = 19.28; 95% CI: 2.01 – 184.94), retire-
ment status (OR = 3.76; 95% CI: 1.17 – 11.98), the length
of time of the relationship (OR = 1.06; 95% CI: 1.00 –
1.11) and tattoos (OR = 7.68; 95% CI: 1.00 – 60.20). After
the exclusion from the analysis of those contacts with
known parenteral exposure we found similar trends in the
risks (table 4), with an increment of risk observed for peo-
ple that had tattoos (OR = 29.09).
It's interesting to remark that a stable sexual relationship
with a HCV positive patient did not affect the seropositiv-
ity in the contacts (OR = 0.86; 95% CI: 0.13 – 5.49).
Discussion
Accurate epidemiological data about the diffusion and
transmission of HCV infection are necessary in order to
understand the burden of the disease. Assessment of HCV
infection prevalence and the identification of all of the
associated risk factors are required in order to plan strate-
gies that will interrupt the different patterns of HCV trans-
mission. It is widely documented that the parental route
is the most important route of HCV transmission: injec-
tion drug use, blood transfusions and other unsafe health-
care related procedures are the most frequently men-
tioned risk factors. Injection drug use is generally consid-
ered to be the major risk factor of new infections in
developed countries, while transfusions and unsafe thera-
peutic injections still represent the main source of infec-
tion transmission in developing areas [19].
On the other hand, data concerning sexual and intrafamil-
ial transmission remain unclear and the role played by the
family in the spread of HCV infection has yet to be
defined. Some case reports have been published that
clearly demonstrate sexual transmission of HCV [20,21].
In addition some epidemiological and case-control stud-
ies have confirmed that intrafamilial transmission occurs
[3,22,23], while others have argued that household expo-
sure non-significantly increases the risk of HCV positivity
[24-26]. This difference in the results of different studies
may be a consequence of several factors such as the ELISA
tests used to detect anti-HCV antibodies (first and second-
generation ELISA used in previous studies have a relatively
low sensitivity in relation to the newer third-generation
assays), geographic area, viremia levels, sexual behaviors
of the subjects studied, selection of the studied popula-
tion, statistical methods used to assess within-household
clusters of HCV infection and genotypes.
We conducted a cross-sectional study on the intrafamilial
transmission of HCV. In our study the prevalence of anti
HCV positivity in all household contacts was 8.9%, which
is higher than in the general population, which is in agree-
ment with other authors. The highest prevalence was
found in sexual partners (12.1%), followed by children
(2.6%). Excluding those with previous parenteral expo-
sure, the proportion of anti-HCV antibodies in family
contacts was 6.2%. These results are similar to the preva-
lence of anti-HCV in our control group (5.2%), support-
ing the hypothesis that Southern Lazio is an area with an
elevated level of HCV in circulation [27]. Moreover, the
prevalence of anti-HCV in sexual contacts (12.1%) was
higher than in non sexual contacts (2.5%), suggesting that
HCV could be sexually transmitted. But re-analyzing data
removing those contacts with known parenteral exposure,
we found that stable sexual relationships cannot be con-
sidered a risk factor. Interestingly, the duration of the rela-
tionship plays a fundamental role in all of the
multivariate analysis models, suggesting that the differ-
ence in the prevalence rates among sexual and non sexual
contacts could be explained simply by a time factor.
Beside this, we found interestingly that being retired from
work is an independent factor associated to HCV positiv-
ity among contacts of HCV chronic patients. This result
does not concur with other studies that have shown that
sexual transmission of HCV may occur in spouses, while
it does confirm that the spreading of the virus to other
Table 4: Results of the logistic regression analysis, without 
patients with known parenteral exposure.
Variables in the model OR° 95% CI p
Job
Manual skilled (reference group) 1
Retired from work 3.61 1.11 – 11.78 0.033
Time of relationship 1.07 1.01 – 1.13 0.018
Tattoos
No (reference group) 1
Yes 29.09 3.28 – 257.99 0.002
(dependent variable: HCV seropositivity in patients' contacts)
°Adjusted for age and sex
Hosmer-Lemeshow Test: p = 0.215
Table 3: Results of the logistic regression analysis.
Variables in the model OR° 95% CI p
Drug addiction
No (reference group) 1
Yes 19.28 2,01 – 184,94 0,010
Job
Manual skilled (reference group) 1
Retired from work 3.76 1.18 – 11.99 0.025
Time of relationship 1.06 1.01 – 1.11 0.038
Tattoos
No (reference group) 1
Yes 7.68 1.00 – 60.20 0.05
(dependent variable: HCV seropositivity in patients' contacts).
°Adjusted for age and sex
Hosmer-Lemeshow Test: p = 0.459BMC Public Health 2006, 6:237 http://www.biomedcentral.com/1471-2458/6/237
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family members seems to be rare [28]. However, there are
conflicting data in the scientific literature regarding sexual
diffusion of HCV. Evidence that supports the hypothesis
for this mode of transmission is that in genotyping the
HCV, some authors have detected the same genotype in
the spousal couple [23,24,29,30]. This is in contrast with
the results obtained from other studies in which the same
genotype was found in very few couples, suggesting that
the risk of sexual transmission was low [31]. Moreover,
the finding that many of the cases of intrafamilial spread
involved siblings suggests that shared use of domestic
objects may played a more important role than sexual
transmission [32]. However, this method of transmission
does not appear to be predominant when compared with
the transmission of other viruses (HIV and HBV) which
can be transmitted by both vertical and horizontal (sexual
and non-sexual) means [33].
Furthermore, we investigated the duration of the relation-
ship with the index cases between anti-HCV positive con-
tacts and anti-HCV negative contacts. According to the
distribution of HCV positive sexual contacts and the dura-
tion of the relationship, the frequency of detection for
anti-HCV increased in proportionately with the duration
of the relationship. This result agrees with the finding of
other studies that anti-HCV positivity increases with the
length of the marriage [29,30,34,35].
The higher prevalence among older contacts may be due
to the duration of the relationship with index cases but
also to some behaviors once common in Italy, such as the
re-use of medical material (syringes for intramuscle injec-
tions) administered at home [36].
Among the risk factors that we analyzed with multivariate
analysis, those significantly associated with HCV positiv-
ity in household contacts were being a drug addict and
having intercourse with drug addicts. Moreover, the
length of exposure and the status of the partner could also
explain the fact that the retirement status is associated
with HCV positivity. As far as drug addiction is concerned,
our survey confirms the findings of other Italian studies
[15,28,37-39].
In a recent review, Ackerman and coll. [40] found that
intrafamilial HCV transmission is associated with the
severity of liver disease in the index patients, the number
of family members infected with HCV, the duration of
exposure and sexual contact with the index patient. Inter-
estingly, out of 67 studies selected in this review, 25.4%
were from Italy. This cross-sectional study confirms that
tattoos are a means of HCV transmission [8].
This study has several limitations. First of all, it is a cross-
sectional study and it was not possible to assess the time-
relationship between types of exposure and outcome
(HCV seropositivity), as in a cohort study. As an example,
we are aware that independent infection among family
members cannot be excluded, and temporal trends cannot
be determined. Anyway, we do know that index cases are
long-term patients so it is likely that family members
became HCV positive after the cases did.
As far as information bias is concerned, this type of error
could have been avoided as we used a very well estab-
lished means of collecting information on past exposures
and risk factors. With regards to selection bias, we col-
lected information regarding the contacts of the index
patients attending our Hepatology Ambulatory in Rome
and from other hospitals in Southern Lazio, and we
believe that our population is a random sample of
patients with HCV in this Region.
Another limitation of the study refers to the lack of assess-
ment for HCV genotype, so we were not able to address
whether differing genotypes have differing rates of trans-
mission.
In conclusion, the substantial percentage of seropositive
contacts with no identifiable risk factors support the
hypothesis of unapparent parenteral transmission of the
virus.
Furthermore, the results of such analyses are useful in gen-
erating hypotheses about possible causes of disease, rather
than drawing defined conclusions [41].
Conclusion
Identification of risk factors for HCV infection and strate-
gies based on these findings have helped contain HCV
infection in many developed countries. However, results
from data on HCV spread through sexual or non-sexual
means in household contacts still remains to be fully
explained.
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